A number of leading sell-side analysts cover our company and regularly write about us. Based on our discussions with the sell-side analysts who publish research on Convatec shares, our understanding of current market consensus as of February 10th, 2025 - comprising 18 analysts - is as follows:  

Disclaimer

Analyst consensus estimates are produced by contributing registered investment analysts currently covering Convatec. The information is provided purely for convenience to users of our website, for information purposes only.

Any opinions, estimates or forecasts that are used to compile the consensus are the sole responsibility of the registered investment analysts, and do not represent opinions, forecasts or predictions of Convatec or its management. By compiling the consensus information, Convatec does not endorse or concur with such analyst information, conclusions or recommendations. 

Convatec has not verified any of the information received and none of Convatec, its affiliates or any of its or their respective directors, officers and employees make any representation or warranty, express or implied, as to, or accepts any responsibility for, the accuracy or completeness of the consensus information. Convatec shall not be liable (whether in contract, tort or otherwise) for any errors, inaccuracies or omissions in the content of the information (either at the date of issue of these forecasts, or any other date), or for any action taken in reliance thereon. Convatec does not assume any responsibility to update, revise or supplement such information.  Convatec may at any time be in possession of information that may affect the analyst’s research and has not commented upon, reviewed or updated, and is under no obligation to comment upon, review or update, their research.

The information provided by Convatec is for information purposes only and is not intended for trading purposes. It should be noted that forecasts are forward-looking and are therefore subject to risks and uncertainties (including unknown risks and uncertainties) that may materially affect eventual results.

We released our FY 2022 numbers on March 8th, 2023. This included some adjustments to our revenue for 2023 following the strategic exit of hospital care and industrial sales. The table below shows the 2022 revenue attributable to these activities.